Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply

Aliment Pharmacol Ther. 2023 Mar;57(5):583-584. doi: 10.1111/apt.17364.

Authors

Josef Wagner^{1

2}, Margaret Littlejohn^{1

3}, Peter A Revill^{1

3}

Affiliations

¹ Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
² Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
³ Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

PMID: 36786457
DOI: 10.1111/apt.17364

No abstract available

Publication types

Editorial

MeSH terms

Haplotypes
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B virus* / genetics
Hepatitis B, Chronic* / drug therapy
Hepatitis B, Chronic* / genetics
Humans
Nucleotides / therapeutic use

Substances

Nucleotides
Hepatitis B Surface Antigens
Hepatitis B e Antigens